These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Prognostic factors in esophageal cancer treated with curative intent. Vendrely V; Launay V; Najah H; Smith D; Collet D; Gronnier C Dig Liver Dis; 2018 Oct; 50(10):991-996. PubMed ID: 30166221 [TBL] [Abstract][Full Text] [Related]
25. Evidence-based review of the management of cancers of the gastroesophageal junction. Narsule CK; Montgomery MM; Fernando HC Thorac Surg Clin; 2012 Feb; 22(1):109-21, vii-viii. PubMed ID: 22108695 [TBL] [Abstract][Full Text] [Related]
26. Perioperative chemo(radio)therapy versus primary surgery for resectable adenocarcinoma of the stomach, gastroesophageal junction, and lower esophagus. Ronellenfitsch U; Schwarzbach M; Hofheinz R; Kienle P; Kieser M; Slanger TE; Jensen K; Cochrane Database Syst Rev; 2013 May; (5):CD008107. PubMed ID: 23728671 [TBL] [Abstract][Full Text] [Related]
27. Clinical outcome of elderly patients (≥ 70 years) with esophageal cancer undergoing definitive or neoadjuvant radio(chemo)therapy: a retrospective single center analysis. Walter F; Böckle D; Schmidt-Hegemann NS; Köpple R; Gerum S; Boeck S; Angele M; Belka C; Roeder F Radiat Oncol; 2018 May; 13(1):93. PubMed ID: 29769143 [TBL] [Abstract][Full Text] [Related]
28. Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer. Shaikh T; Meyer JE; Horwitz EM Surg Oncol Clin N Am; 2017 Jul; 26(3):405-429. PubMed ID: 28576180 [TBL] [Abstract][Full Text] [Related]
29. Should Multidisciplinary Treatment Differ for Esophageal Adenocarcinoma Versus Esophageal Squamous Cell Cancer? Cools-Lartigue J; Ferri L Ann Surg Oncol; 2019 Apr; 26(4):1014-1027. PubMed ID: 30675706 [TBL] [Abstract][Full Text] [Related]
30. [Multimodal treatment of esophageal carcinoma]. Graf D; Vallböhmer D; Knoefel WT; Budach W; Häussinger D Dtsch Med Wochenschr; 2014 Oct; 139(42):2141-7. PubMed ID: 25289924 [TBL] [Abstract][Full Text] [Related]
31. [Treatment of esophageal cancer]. Yang DH; Jung HY Korean J Gastroenterol; 2008 Dec; 52(6):338-50. PubMed ID: 19096251 [TBL] [Abstract][Full Text] [Related]
33. Management of Dysphagia in Esophageal Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy: Can Invasive Tube Feeding be Avoided? Cools-Lartigue J; Jones D; Spicer J; Zourikian T; Rousseau M; Eckert E; Alcindor T; Vanhuyse M; Asselah J; Ferri LE Ann Surg Oncol; 2015; 22(6):1858-65. PubMed ID: 25476030 [TBL] [Abstract][Full Text] [Related]
34. Current status of management of malignant disease: current management of esophageal cancer. Cools-Lartigue J; Spicer J; Ferri LE J Gastrointest Surg; 2015 May; 19(5):964-72. PubMed ID: 25650163 [TBL] [Abstract][Full Text] [Related]
35. Neoadjuvant treatments for locally advanced, resectable esophageal cancer: A network meta-analysis. Chan KKW; Saluja R; Delos Santos K; Lien K; Shah K; Cramarossa G; Zhu X; Wong RKS Int J Cancer; 2018 Jul; 143(2):430-437. PubMed ID: 29441562 [TBL] [Abstract][Full Text] [Related]
36. Combined modality therapy of localized gastric and esophageal cancers. Das P; Fukami N; Ajani JA J Natl Compr Canc Netw; 2006 Apr; 4(4):375-82. PubMed ID: 16569390 [TBL] [Abstract][Full Text] [Related]
37. Preoperative and adjuvant therapies for upper gastrointestinal cancers. Varadhachary G; Ajani JA Expert Rev Anticancer Ther; 2005 Aug; 5(4):719-25. PubMed ID: 16111471 [TBL] [Abstract][Full Text] [Related]
38. Nodal metastasis from locally advanced esophageal cancer: how neoadjuvant therapy modifies their frequency and distribution. Castoro C; Scarpa M; Cagol M; Ruol A; Cavallin F; Alfieri R; Zanchettin G; Rugge M; Ancona E Ann Surg Oncol; 2011 Dec; 18(13):3743-54. PubMed ID: 21556952 [TBL] [Abstract][Full Text] [Related]
39. Perioperative chemotherapy vs. neoadjuvant chemoradiation in gastroesophageal junction adenocarcinoma : A population-based evaluation of the Munich Cancer Registry. Münch S; Habermehl D; Agha A; Belka C; Combs SE; Eckel R; Friess H; Gerbes A; Nüssler NC; Schepp W; Schmid RM; Schmitt W; Schubert-Fritschle G; Weber B; Werner J; Engel J Strahlenther Onkol; 2018 Feb; 194(2):125-135. PubMed ID: 29071366 [TBL] [Abstract][Full Text] [Related]
40. Neoadjuvant chemoradiotherapy with concurrent cisplatin/5-fluorouracil is associated with increased pathologic complete response and improved survival compared to carboplatin/paclitaxel in patients with locally advanced esophageal cancer. Haisley KR; Hart KD; Nabavizadeh N; Bensch KG; Vaccaro GM; Thomas CR; Schipper PH; Hunter JG; Dolan JP Dis Esophagus; 2017 Jul; 30(7):1-7. PubMed ID: 28475724 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]